Imprimis Pharmaceuticals is an ophthalmology-focused pharmaceutical company focused on the development, production and sale of medications. Co. operates its business through several subsidiaries: ImprimisRx, an ophthalmology focused compounding business; Park Compounding, a custom compounding business focused on patient specific orders; and Surface Pharmaceuticals, Inc., an ocular surface disease-focused 505(b)(2) specialty pharmaceutical subsidiary. We show 26 historical shares outstanding datapoints in our IMMY shares outstanding history coverage, used to compute IMMY market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing IMMY market cap history over the course of time is important for investors
interested in comparing IMMY's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of IMMY versus a peer is one thing; comparing
IMMY market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like IMMY can fluctuate over the course of history.
With this page we aim to empower investors researching IMMY by allowing them to research the IMMY market cap history. |
Free IMMY Email Alerts:
Video: The Importance of Market Cap
